C.R. Bard announces W. L. Gore & Associates files request for Judicial Notice In a regulatory filing, C. R. Bard announced that W. L. Gore & Associates filed with the U.S. District Court for the District of Arizona a Request for Judicial Notice that the U.S. Patent and Trademark Office granted Goreís previously filed request for a re-examination of Bard patent number 6,436,135 which is the subject of Bardís patent infringement suit against Gore. The company does not believe that this will materially impact the litigation proceedings.
News For BCR From The Last 14 Days
Check below for free stories on BCR the last two weeks.
Medtronic data positive for C.R. Bard, says Barclays Barclays said Medtronic's (MDT) better than expected drug coated balloon data could have a positive class effect that benefits C.R. Bard (BCR). The firm reiterates its Overweight rating C.R. Bard and raised its price target to $165 from $160. Note that BofA/Merrill downgraded C.R. Bard to Neutral from Buy following the Medtronic's news.